SCHEMBL22149665

SCHEMBL22149665

C/N=C(/COCc1ccccc1)N(C)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.44
▸ ALDH1A1 P00352 3/20 0.38
▸ MAPT P10636 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ MEN1 O00255 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ NAAA Q02083 1/20 0.36
▸ CA1 P00915 2/20 0.36
▸ CA2 P00918 2/20 0.36
▸ CA9 Q16790 2/20 0.36
▸ FAAH O00519 1/20 0.36
▸ PHGDH O43175 1/20 0.36
▸ MGLL Q99685 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA7 P43166 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23864902 0.82 ALDH1A1 (0.43) TSHRALDH1A1MAPTMEN1KMT2A
SCHEMBL22312249 0.79 KMT2A (0.52) ALDH1A1MEN1GAAKMT2ANPC1
SCHEMBL22276261 0.75 FAAH (0.42) TSHRALDH1A1MEN1KMT2ALMNA
SCHEMBL10108195 0.74 TSHR (0.52) TSHRALDH1A1MAPTLMNANPC1
SCHEMBL21480025 0.74 NPC1 (0.46) ALDH1A1MAPTHPGDMEN1GAA
SCHEMBL20419648 0.73 FAAH (0.40) ALDH1A1HPGDMEN1KMT2ALMNA
Trimethylammonium SCHEMBL27954231 0.70 TSHR (0.79) TSHRALDH1A1MAPTCA1CA2
SCHEMBL1019064 0.70 PPIB (0.52) ALDH1A1MAPTHPGDMEN1GAA
SCHEMBL2290221 0.69 SMN1; SMN2 (0.51) TSHRALDH1A1MAPTHPGDKMT2A
SCHEMBL5450319 0.69 TSHR (0.61) TSHRALDH1A1MAPTNPC1CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020125391-A1 AMINOPYRIMIDINE COMPOUND USED FOR INHIBITING ACTIVITY OF PROTEIN KINASE 深圳市塔吉瑞生物医药有限公司 2020-06-25 — — WO disclosed
Send feedback